Cardiol Therapeutics Inc.(CRDL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Cardiol Therapeutics Inc. (CRDL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CRDL is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.1m in revenue and is scored on the micro-cap board instead. Top institutional holders of CRDL by reported 13-F value include MMCAP International SPC, Tejara Capital Ltd, Ikarian Capital, based on the most recent SEC filings. CRDL trades on the Nasdaq exchange and files with the SEC under CIK 1702123. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CRDL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardiol Therapeutics Inc. directly from SEC EDGAR.

CRDL key financials by period

Cardiol Therapeutics Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202120-F$78.8K——

Institutions holding CRDL

Institutional investors reporting a position in Cardiol Therapeutics Inc. on SEC Form 13F.
InstitutionSharesValueReported
MMCAP International SPC15,598,560$16.5M2026-06-30
Tejara Capital Ltd5,113,822$5.4M2026-06-30
Ikarian Capital3,325,000$3.5M2026-06-30
BOOTHBAY FUND MANAGEMENT975,721$1.0M2026-06-30
CITADEL ADVISORS796,529$844.3K2026-06-30
RENAISSANCE TECHNOLOGIES772,837$819.2K2026-06-30
TWO SIGMA INVESTMENTS746,937$791.8K2026-06-30
INTEGRITY ALLIANCE388,492$411.8K2026-06-30
MORGAN STANLEY355,030$376.3K2026-06-30
GOLDMAN SACHS GROUP333,900$353.9K2026-06-30
SEC EDGAR: CIK 1702123 →
CRDL

Cardiol Therapeutics Inc.

CRDL
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.1M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$31.35M total
MMCAP International Inc. SPC
$16.53M+1.6%
Tejara Capital Ltd
$5.42M-0.3%
Ikarian Capital, LLC
$3.52M+22.0%
BOOTHBAY FUND MANAGEMENT, LLC
$1.03M+22.8%
CITADEL ADVISORS LLC
$844.3K+939.9%
RENAISSANCE TECHNOLOGIES LLC
$819.2K+236.3%
TWO SIGMA INVESTMENTS, LP
$791.8K+39.8%
INTEGRITY ALLIANCE, LLC.
$411.8K-16.5%
MORGAN STANLEY
$376.3K+41.8%
GOLDMAN SACHS GROUP INC
$353.9K+0.5%
Loading ratio trend…